Inverse Gottron's papules: An unusual cutaneous manifestation of juvenile dermatomyositis

Pediatric Dermatology

Volumn 29, Issue 5, 2012, Pages 641-644

  Quinter, Suzanne D ^a   Chiu, Yvonne E ^a   Lyon, Valerie B ^a   Holland, Kristen E ^a   Ruggeri, Sun Young ^a   Drolet, Beth A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ANKLE; ARTICLE; ASIAN; CASE REPORT; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG TREATMENT FAILURE; ELBOW; FEMALE; HAND; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; INVERSE GOTTRON PAPULE; JUVENILE DERMATOMYOSITIS; KNEE; LUNG INFILTRATE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ANDROSTADIENES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TREATMENT OUTCOME;

EID: 84866378073     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01585.x     Document Type: Article

References (12)

1. Bohan A, Peter JB,. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.
2. Bohan A, Peter JB,. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
3. Wong KO,. Dermatomyositis: a clinical investigation of twenty-three cases in Hong Kong. Br J Dermatol 1969; 81: 544-547.
4. del Pozo J, Almagro M, Martinez W, et al., Dermatomyositis and mucinosis. Int J Dermatol 2001; 40: 120-124.
5. Sasaki Y, Okuyama R, Tsunoda T, et al., Keratotic palmar papules in a dermatomyositis patient preceding the development of interstitial pneumonia. Dermatol 2007; 215: 169-170.
6. Kameda H, Nagasawa H, Ogawa H, et al., Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005; 32: 1719-1726.
7. Fujikawa K, Kawakami A, Kaji K, et al., Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol 2009; 38: 263-267.
8. Hoshino K, Muro Y, Sugiura K, et al., Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatol (Oxford) 2010; 49: 1726-1733.
9. Sato S, Hoshino K, Satoh T, et al., RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009; 60: 2193-2200.
10. Kobayashi I, Okura Y, Yamada M, et al., Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis. J Pediatr 2011; 158: 675-677.
11. Hirakata M, Nagai S,. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12: 501-508.
12. Morganroth PA, Kreider ME, Okawa J, et al., Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol 2010; 146: 729-738.